Header Logo

Connection

Marta Batus to Bevacizumab

Back to Details
This is a "connection" page, showing publications Marta Batus has written about Bevacizumab.
Marta Batus
Connection Strength
0.035
Bevacizumab
  1. Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience. Pediatr Blood Cancer. 2017 04; 64(4).
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.